Answers are grounded in this paper and cite their sources.
Selected N-glycans improve type 2 diabetes and CVD prediction beyond established risk markers. Plasma protein N-glycan profiling may thus be useful for risk stratification in the context of precisely targeted primary prevention of cardiometabolic diseases.
No takes yet. Share an insight, caveat, or question.
Wittenbecher et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: